SGP
SpyGlass Pharma, Inc.
24.90$
-6.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
SpyGlass Pharma, Inc. (SGP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -6.2 | -8.2 | -6.3 | -8.8 | -9.3 | -14 | -15 | -47 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 1.0 | |
| 0.4 | 0.3 | 0.6 | 0.9 | 0.9 | 1.7 | 2.1 | 5.6 | |
| 0.7 | -1.5 | 1.5 | -0.2 | 2.6 | -1.8 | 2.5 | 3.1 | |
| 0.4 | 0.2 | 0.1 | 0.2 | 0.4 | 0.7 | 1.9 | 3.2 | |
| – | – | – | -12 | 0.6 | -1.7 | -0.9 | -14 | |
| – | – | – | 0.0 | 0.0 | – | – | – | |
| 0.1 | 50 | 76 | -0.2 | -0.9 | 158 | 0.0 | 157 | |
| -2.1 | 42 | 69 | -21 | -9.6 | 143 | -16 | 96 | |
| -6.7 | -8.4 | -6.4 | -9.0 | -9.8 | -14 | -17 | -50 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.